Neodidro (Calcifediol)

Neodidro is a pharmaceutical product containing Calcifediol, used primarily to treat Vitamin D deficiency and related metabolic bone diseases. It is manufactured and marketed by Bruno Farmaceutici S.p.A., an established Italian pharmaceutical company.

Originally founded in Rome, Bruno Farmaceutici has maintained its independence and specializes in therapeutic areas such as metabolic disorders, cardiovascular health, and rheumatology. The product is manufactured in Italy, adhering to strict European medical standards. As of 2024 and beyond, the brand remains under the ultimate ownership of its founding Italian entity, emphasizing its heritage in the Italian pharmaceutical industry.